Literature DB >> 39040

[Discontinuation of neuroleptics in chronic schizophrenics. I. Summary of the literature].

B Woggon.   

Abstract

Based on the available publications on the discontinuation of antipsychotic drug treatment in chronic schizophrenic patients the following conclusions can be drawn: (1) About 50% of chronic schizophrenic patients develop a psychotic relapse after discontinuation of antipsychotic drug treatment. (2) The risk for a psychotic relapse after neuroleptic withdrawal seems to be less pronounced in older patients with a long duration of illness and hospitalization who are treated with a rather low maintenance dosage of antipsychotic drugs. (3) For the individual patient the effects of discontinuation are only predictable based on earlier results of an individual termination of his antipsychotic drug treatment.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 39040

Source DB:  PubMed          Journal:  Int Pharmacopsychiatry        ISSN: 0020-8272


  1 in total

1.  A depot neuroleptic withdrawal study. Plasma concentration of fluphenazine and flupenthixol and relapse frequency.

Authors:  B Wistedt; A Jørgensen; D Wiles
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.